Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Circulatory system drugs >  Antiarrhythmics Drugs >  Nifekalant hydrochloride

Nifekalant hydrochloride

Basic information Safety Supplier Related

Nifekalant hydrochloride Basic information

Product Name:
Nifekalant hydrochloride
Synonyms:
  • 1,3-Dimethyl-6-[2-(N-(2-hydroxyethyl)-3-(4-nitrophenyl)propylamino)ethylamino]-2,4(1H,3H)-pyrimidinedione hydrochloride
  • Nifekalant 130636-43-0 /
  • 1,3-Dimethyl-6-((2-(N-(2-hydroxyethyl)-3-(4-nitrophenyl)propylamino)ethylamino)-2,4(1H),3H)-pyrimidinedione HCl
  • 2,4(1H,3H)-Pyrimidinedione, 6-((2-((2-hydroxyethyl)(3-(4-nitrophenyl)propyl)amino)ethyl)amino)-1,3-dimethyl-, monohydrochloride
  • 6-[[2-[(2-Hydroxyethyl)[3-(4-nitrophenyl)propyl]aMino]ethyl]aMino]-1,3-diMethyl-2,4(1H,3H)-pyriMidinedione Hydrochloride
  • Shinbit
  • ms551
  • NIFEKALANT HYDROCHLORIDE
CAS:
130656-51-8
MF:
C19H28ClN5O5
MW:
441.91
EINECS:
1533716-785-6
Product Categories:
  • Inhibitors
  • Amines
  • Aromatics
  • Heterocycles
  • Intermediates & Fine Chemicals
  • Pharmaceuticals
Mol File:
130656-51-8.mol
More
Less

Nifekalant hydrochloride Chemical Properties

Melting point:
172-174°
storage temp. 
Refrigerator
solubility 
DMSO (Slightly, Heated), Methanol (Slightly, Heated), Water (Slightly)
form 
Solid
pka
7.05(at 25℃)
color 
Light Yellow to Yellow
CAS DataBase Reference
130656-51-8(CAS DataBase Reference)
More
Less

Nifekalant hydrochloride Usage And Synthesis

Description

Nifekalant is a novel and pure class III anti-arrhythmic agent introduced in Japan as Shinbit injection for the treatment of serious ventricular arrhythmias. It can be synthesized in 3 steps with a final assembly of two ethanolamine blocks. Nifekalant is a non-selective blocker of myocardial repolarizing potassium currents and is completely devoid of any β-adrenergic blocking effect . In hearts from different species, Nifekalant significantly prolonged action potential duration, atrial and ventricular refractory periods in in situ and in isolation studies. In intact animals, hemodynamic parameters were not affected by doses up to 1 mg/kg. The specific characteristics of its voltage- and timedependent K+ current blockade might differentiate Nifekalant from other class III agents currently in use.

Description

Nifekalant is a class III antiarrhythmic agent that has been shown to be beneficial to initial resuscitation after cardiac arrest in clinical trials. It blocks the rapidly activating delayed rectifier potassium channel (IKr; IC50 = 10 μM). Nifekalant is also inhibits the human multidrug and toxin extrusion (MATE) transporter 1 (MATE1; IC50 = 6.5 μM).

Chemical Properties

Yellow Solid

Originator

Mitsui (Japan)

Uses

Nifekalant Hydrochloride is a class III antiarrhythmic agent. Nifekalant Hydrochloride is used in the treatment of patients with extensive anterior infarction and severe ventricular dysfunction.

Definition

ChEBI: Nifekalant hydrochloride is an amine. It contains a Nifekalant.

brand name

Shinbit

Nifekalant hydrochloride Supplier

Sichuan Baili Pharmaceutical Co., Ltd. Gold
Tel
028-85183639
Email
baili@baili-pharm.com
ChemeGen(Shanghai) Biotechnology Co.,Ltd. Gold
Tel
18818260767
Email
sales@chemegen.com
J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
Chemsky（shanghai）International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
XiaoGan ShenYuan ChemPharm co,ltd
Tel
15527768850
Email
1791901229@qq.com
More
Less

Nifekalant hydrochloride (130656-51-8)Related Product Information